UNK MAMMARY IMPLANT
Report
- Report Number
- 9617229-2025-10893
- Event Type
- Injury
- Date Received
- July 1, 2025
- Date of Event
- December 1, 2024
- Report Date
- June 30, 2025
- Manufacturer
- ALLERGAN (COSTA RICA)
- Product Code
- FWM
- PMA / PMN Number
- P990074
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
ARTICLE CITATION: XU, P., KOURENTZI, K., WILLSON, R., HU, H., DEVA, A., MCGUIRE, P., GLICKSMAN, C., & KADIN, M. (2024). IL-9 IS A BIOMARKER OF BIA-ALCL DETECTED RAPIDLY BY LATERAL FLOW ASSAY. AESTHETIC SURGERY JOURNAL, 44(12), 1286¿1292. CLARIFICATION TO B5 DESCRIPTION OF EVENT: AS THERE ARE NO SPECIFICS REGARDING WHICH PATIENTS WERE DIAGNOSED WITH ALCL FROM EACH COUNTRY, THIS RECORD REPRESENTS THE 11 TOTAL POSSIBLE BIA-ALCL DIAGNOSES AMONG THE 14 US PATIENTS AND 12 AUSTRALIA PATIENTS. THE EVENTS OF "LYMPHOMA-ALCL-SUSPECTED" AND "SEROMA-LATE" ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ABBVIE IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: "MALIGNANT SEROMAS"; DIAGNOSIS OF BIA-ALCL.
THROUGH JOURNAL ARTICLE "IL-9 IS A BIOMARKER OF BIA-ALCL DETECTED RAPIDLY BY LATERAL FLOW ASSAY", HEALTHCARE PROFESSIONAL REPORTED ANALYZING ¿UNUSED PORTIONS OF 26 SEROMAS (15 BENIGN, 11 MALIGNANT)" FROM 14 US PATIENTS AND 12 AUSTRALIA PATIENTS. AT LEAST 6 OF THE 11 MALIGNANT SEROMA SAMPLES ARE FROM PATIENTS WITH ALLERGAN-MANUFACTURED DEVICES, ALL OF WHICH WERE DIAGNOSED AS "ALCL-IA". PATHOLOGICAL MARKER CD30+ WAS RECEIVED. PATHOLOGICAL MARKER ALK- WAS NOT RECEIVED. STATUS OF DEVICES AND AFFECTED SIDES ARE UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1314175 | UNK MAMMARY IMPLANT | PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE | FWM | ALLERGAN (COSTA RICA) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention| L |